MarketCap
Facebook
X
Telegram
Affimed N.V. DSO Ratio | AFMD
Annual DSO Ratio Affimed N.V.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 31.4 | 25.3 | 22 | 200 | 130 | 44.2 | 97.2 | - | - | - |
Annual performance
Select metrics to display
All numbers in EUR currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 200 | 22 | 78.6 |
DSO Ratio of other stocks in the Biotechnology industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Kadmon Holdings, Inc.
KDMN
|
30.6 | - | - | $ 1.7 B |  USA |
 |
Liminal BioSciences
LMNL
|
429 | - | - | $ 256 M |  Canada |
 |
XBiotech
XBIT
|
40.8 | $ 1.97 | 3.2 % | $ 60.1 M | USA |
 |
Neos Therapeutics, Inc.
NEOS
|
150 | - | -2.54 % | $ 57.2 M | USA |
 |
Osmotica Pharmaceuticals plc
OSMT
|
54.2 | - | -10.74 % | $ 89.9 M | USA |
 |
Pandion Therapeutics, Inc.
PAND
|
0.0395 | - | - | $ 1.77 B | USA |
 |
Xenetic Biosciences
XBIO
|
365 | $ 1.76 | -2.09 % | $ 2.99 M | USA |
 |
Translate Bio, Inc.
TBIO
|
69.9 | - | - | $ 2.81 B | USA |
 |
Trillium Therapeutics Inc.
TRIL
|
2.34 K | - | - | $ 1.94 B | Canada |
 |
Acceleron Pharma Inc.
XLRN
|
42.2 | - | - | $ 10.9 B | USA |
 |
Zealand Pharma A/S
ZEAL
|
75.3 | - | 0.52 % | $ 821 M |  Danmark |
 |
Zogenix, Inc.
ZGNX
|
102 | - | -4.97 % | $ 664 M | USA |
 |
ZIOPHARM Oncology, Inc.
ZIOP
|
4.66 K | - | -7.58 % | $ 264 M | USA |
 |
Xenon Pharmaceuticals
XENE
|
35.7 | $ 41.4 | 2.35 % | $ 3.28 B | Canada |
 |
Leap Therapeutics
LPTX
|
17.8 | - | 368.57 % | $ 41.9 M | USA |
 |
Zymeworks
ZYME
|
211 | $ 31.45 | 2.08 % | $ 1.62 B | Canada |
 |
ADMA Biologics
ADMA
|
74.6 | $ 12.67 | -0.98 % | $ 3.02 B | USA |
 |
Daré Bioscience
DARE
|
877 | $ 0.69 | 1.75 % | $ 7.71 M | USA |
 |
Fate Therapeutics
FATE
|
122 | $ 1.78 | -8.51 % | $ 211 M | USA |
 |
Halozyme Therapeutics
HALO
|
93.4 | $ 103.0 | 0.08 % | $ 12.3 B | USA |
 |
Hutchison China MediTech Limited
HCM
|
93.9 | $ 15.34 | 0.1 % | $ 13.2 B |  China |
 |
Aptorum Group Limited
APM
|
94 | - | - | $ 5.72 M | China |
 |
iBio
IBIO
|
138 | $ 0.78 | -1.89 % | $ 81.2 M | USA |
 |
Karyopharm Therapeutics
KPTI
|
71.1 | $ 0.02 | -54.5 % | $ 219 | USA |
 |
FSD Pharma
HUGE
|
2.94 K | - | 5743.5 % | $ 69.7 M | Canada |
 |
Catalyst Pharmaceuticals
CPRX
|
59.5 | - | - | $ 3.85 B | USA |
 |
UroGen Pharma Ltd.
URGN
|
88.7 | $ 25.32 | -3.78 % | $ 1.22 B |  Israel |
 |
Catalyst Biosciences
CBIO
|
79.3 | $ 13.91 | 1.9 % | $ 1.24 B | USA |
 |
Acasti Pharma
ACST
|
1.97 | - | 4.01 % | $ 150 M | Canada |
 |
ADiTx Therapeutics
ADTX
|
6.94 K | - | - | $ 374 | USA |
 |
Aeterna Zentaris
AEZS
|
146 | - | 5.93 % | $ 314 M | Canada |
 |
AgeX Therapeutics
AGE
|
186 | - | -10.17 % | $ 12.2 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
216 | - | - | $ 1.01 B | USA |
 |
AIkido Pharma
AIKI
|
17.9 | - | 1.93 % | $ 17.4 M | USA |
 |
Apellis Pharmaceuticals
APLS
|
115 | - | - | $ 5.18 B | USA |